|
SGK269 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.41390035632594E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.02660102641039E-11 |
| Normal-vs-Stage2 |
2.172400E-02 |
| Normal-vs-Stage3 |
2.184900E-04 |
| Normal-vs-Stage4 |
5.875900E-02 |
| Stage1-vs-Stage2 |
1.108040E-02 |
| Stage1-vs-Stage3 |
6.724100E-02 |
| Stage1-vs-Stage4 |
3.383100E-03 |
| Stage2-vs-Stage3 |
4.425800E-01 |
| Stage2-vs-Stage4 |
6.978800E-01 |
| Stage3-vs-Stage4 |
2.044400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.24420029834482E-10 |
| Normal-vs-AfricanAmerican |
1.291180E-01 |
| Normal-vs-Asian |
1.893430E-01 |
| Caucasian-vs-AfricanAmerican |
7.705700E-02 |
| Caucasian-vs-Asian |
6.854600E-01 |
| AfricanAmerican-vs-Asian |
3.356600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.75470004982037E-09 |
| Normal-vs-Female |
4.99550000032656E-07 |
| Male-vs-Female |
7.776200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.622400E-02 |
| Normal-vs-Age(41-60Yrs) |
5.73640024370548E-10 |
| Normal-vs-Age(61-80Yrs) |
2.43970000002314E-06 |
| Normal-vs-Age(81-100Yrs) |
4.702600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.713600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.177800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.962430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.383800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.393700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.796000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.779300E-03 |
| Normal-vs-Grade 2 |
4.64309701797561E-11 |
| Normal-vs-Grade 3 |
5.6865000000017E-05 |
| Normal-vs-Grade 4 |
2.795500E-02 |
| Grade 1-vs-Grade 2 |
2.896800E-01 |
| Grade 1-vs-Grade 3 |
1.400280E-02 |
| Grade 1-vs-Grade 4 |
3.849500E-02 |
| Grade 2-vs-Grade 3 |
3.140100E-03 |
| Grade 2-vs-Grade 4 |
2.558000E-02 |
| Grade 3-vs-Grade 4 |
7.532600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.93169990692877E-11 |
| Normal-vs-ccB subtype |
3.38530000032478E-07 |
| ccA subtype-vs-ccB subtype |
4.733200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.49730000304538E-08 |
| Normal-vs-N1 |
5.614600E-01 |
| N0-vs-N1 |
2.095800E-01 |
|
|
